Derek Lowe on FDA's about-face approval of Sarepta’s 2nd drug for muscular dystrophy (golodirsen) just months after sending the company a complete response letter, which enumerated multiple problems #NBTInTheirWords https://blogs.sciencemag.org/pipeline/archives/2020/01/22/opening-the-lid-on-sareptas-drug-approvals …pic.twitter.com/2uJ3FowCya
08:09 - 23. sij 2020.
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.